74.82 USD
-0.43 (-0.57%)
We assign a fundamental rating of 4 out of 10 to HSIC. HSIC was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HSIC while its profitability can be described as average. HSIC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year HSIC was profitable.
In the past year HSIC had a positive cash flow from operations.
HSIC had positive earnings in each of the past 5 years.
In the past 5 years HSIC always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of HSIC (3.52%) is better than 67.33% of its industry peers.
HSIC has a Return On Equity of 11.63%. This is in the better half of the industry: HSIC outperforms 76.24% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.64%, HSIC is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
HSIC had an Average Return On Invested Capital over the past 3 years of 8.02%. This is in line with the industry average of 9.27%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROIC | 6.64% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
1.3 Margins
Looking at the Profit Margin, with a value of 3.02%, HSIC is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
HSIC's Profit Margin has declined in the last couple of years.
HSIC has a Operating Margin of 5.94%. This is in the better half of the industry: HSIC outperforms 62.38% of its industry peers.
In the last couple of years the Operating Margin of HSIC has declined.
HSIC has a Gross Margin (31.19%) which is in line with its industry peers.
HSIC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% |
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HSIC has been reduced compared to 1 year ago.
The number of shares outstanding for HSIC has been reduced compared to 5 years ago.
HSIC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.66 indicates that HSIC is not a great score, but indicates only limited risk for bankruptcy at the moment.
HSIC has a Altman-Z score of 2.66. This is comparable to the rest of the industry: HSIC outperforms 57.43% of its industry peers.
HSIC has a debt to FCF ratio of 8.70. This is a slightly negative value and a sign of low solvency as HSIC would need 8.70 years to pay back of all of its debts.
HSIC has a Debt to FCF ratio of 8.70. This is comparable to the rest of the industry: HSIC outperforms 50.49% of its industry peers.
HSIC has a Debt/Equity ratio of 0.91. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.91, HSIC perfoms like the industry average, outperforming 41.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Altman-Z | 2.66 |
ROIC/WACC0.77
WACC8.58%
2.3 Liquidity
HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
HSIC's Current ratio of 1.40 is in line compared to the rest of the industry. HSIC outperforms 49.51% of its industry peers.
HSIC has a Quick Ratio of 1.40. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.79, HSIC is not doing good in the industry: 76.24% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.49% over the past year.
Measured over the past 5 years, HSIC shows a small growth in Earnings Per Share. The EPS has been growing by 6.19% on average per year.
HSIC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.51%.
The Revenue has been growing slightly by 4.88% on average over the past years.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
3.2 Future
HSIC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.39% yearly.
HSIC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.05% yearly.
EPS Next Y3.76%
EPS Next 2Y5.94%
EPS Next 3Y7.19%
EPS Next 5Y7.39%
Revenue Next Year1.74%
Revenue Next 2Y2.59%
Revenue Next 3Y2.89%
Revenue Next 5Y3.05%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.52, HSIC is valued correctly.
82.18% of the companies in the same industry are more expensive than HSIC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HSIC to the average of the S&P500 Index (26.15), we can say HSIC is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.06, the valuation of HSIC can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 79.21% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of HSIC to the average of the S&P500 Index (36.12), we can say HSIC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.52 | ||
| Fwd PE | 14.06 |
4.2 Price Multiples
HSIC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 73.27% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as HSIC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.49 | ||
| EV/EBITDA | 10.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HSIC may justify a higher PE ratio.
PEG (NY)4.12
PEG (5Y)2.51
EPS Next 2Y5.94%
EPS Next 3Y7.19%
5. Dividend
5.1 Amount
No dividends for HSIC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HSIC (11/28/2025, 10:42:57 AM)
74.82
-0.43 (-0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.98%
Inst Owner Change-5%
Ins Owners0.77%
Ins Owner Change-0.15%
Market Cap9.07B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts69.57
Price Target78.71 (5.2%)
Short Float %8.18%
Short Ratio5.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)5.05%
PT rev (3m)6.5%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-0.29%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.52 | ||
| Fwd PE | 14.06 | ||
| P/S | 0.7 | ||
| P/FCF | 25.49 | ||
| P/OCF | 16.96 | ||
| P/B | 2.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.4 |
EPS(TTM)4.82
EY6.44%
EPS(NY)5.32
Fwd EY7.11%
FCF(TTM)2.94
FCFY3.92%
OCF(TTM)4.41
OCFY5.9%
SpS106.69
BVpS27.72
TBVpS-15.11
PEG (NY)4.12
PEG (5Y)2.51
Graham Number54.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROCE | 9.68% | ||
| ROIC | 6.64% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 16.65% | ||
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% | ||
| FCFM | 2.75% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 58.69% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 5.16 | ||
| Cash Conversion | 49.81% | ||
| Profit Quality | 91.05% | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.66 |
F-Score5
WACC8.58%
ROIC/WACC0.77
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y3.76%
EPS Next 2Y5.94%
EPS Next 3Y7.19%
EPS Next 5Y7.39%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year1.74%
Revenue Next 2Y2.59%
Revenue Next 3Y2.89%
Revenue Next 5Y3.05%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year14.87%
EBIT Next 3Y8.36%
EBIT Next 5YN/A
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%
HENRY SCHEIN INC / HSIC FAQ
Can you provide the ChartMill fundamental rating for HENRY SCHEIN INC?
ChartMill assigns a fundamental rating of 4 / 10 to HSIC.
Can you provide the valuation status for HENRY SCHEIN INC?
ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.
Can you provide the profitability details for HENRY SCHEIN INC?
HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HENRY SCHEIN INC?
The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 3.76% in the next year.